259 related articles for article (PubMed ID: 26038829)
1. Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity.
Jean SR; Tulumello DV; Riganti C; Liyanage SU; Schimmer AD; Kelley SO
ACS Chem Biol; 2015 Sep; 10(9):2007-15. PubMed ID: 26038829
[TBL] [Abstract][Full Text] [Related]
2. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB
Cell Biol Toxicol; 2009 Jun; 25(3):227-43. PubMed ID: 18386138
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
Upadhyay S; Mantha AK; Dhiman M
J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
5. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l-mediated mitochondrial fission.
Aung LHH; Li R; Prabhakar BS; Li P
J Cell Mol Med; 2017 Dec; 21(12):3394-3404. PubMed ID: 28643438
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.
Cui L; Guo J; Zhang Q; Yin J; Li J; Zhou W; Zhang T; Yuan H; Zhao J; Zhang L; Carmichael PL; Peng S
Toxicol Lett; 2017 Jun; 275():28-38. PubMed ID: 28456571
[TBL] [Abstract][Full Text] [Related]
8. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
[TBL] [Abstract][Full Text] [Related]
9. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
[TBL] [Abstract][Full Text] [Related]
12. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria as a Target for the Cardioprotective Effects of Cydonia oblonga Mill. and Ficus carica L. in Doxorubicin-Induced Cardiotoxicity.
Gholami S; Hosseini MJ; Jafari L; Omidvar F; Kamalinejad M; Mashayekhi V; Hosseini SH; Kardan A; Pourahmad J; Eskandari MR
Drug Res (Stuttg); 2017 Jun; 67(6):358-365. PubMed ID: 28320040
[TBL] [Abstract][Full Text] [Related]
14. Adipocytokine, omentin inhibits doxorubicin-induced H9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species.
Kazama K; Okada M; Yamawaki H
Biochem Biophys Res Commun; 2015 Feb; 457(4):602-7. PubMed ID: 25600813
[TBL] [Abstract][Full Text] [Related]
15. A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells.
Wang L; Zhang X; Chan JY; Shan L; Cui G; Cui Q; Wang Y; Li J; Chen H; Zhang Q; Yu P; Han Y; Wang Y; Lee SM
J Cell Biochem; 2016 Jan; 117(1):94-105. PubMed ID: 26058377
[TBL] [Abstract][Full Text] [Related]
16. Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling.
Dhingra R; Margulets V; Chowdhury SR; Thliveris J; Jassal D; Fernyhough P; Dorn GW; Kirshenbaum LA
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5537-44. PubMed ID: 25489073
[TBL] [Abstract][Full Text] [Related]
17. In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates.
Patil V; Gada K; Panwar R; Majewski S; Tekabe Y; Varvarigou A; Khaw BA
J Drug Target; 2013 Dec; 21(10):1012-21. PubMed ID: 23863118
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin.
Segredo MP; Salvadori DM; Rocha NS; Moretto FC; Correa CR; Camargo EA; de Almeida DC; Reis RA; Freire CM; Braz MG; Tang G; Matsubara LS; Matsubara BB; Yeum KJ; Ferreira AL
Hum Exp Toxicol; 2014 Jul; 33(7):748-60. PubMed ID: 24275640
[TBL] [Abstract][Full Text] [Related]
19. Grape seed proanthocyanidins ameliorate Doxorubicin-induced cardiotoxicity.
Li J; Liu H; Ramachandran S; Waypa GB; Yin JJ; Li CQ; Han M; Huang HH; Sillard WW; Vanden Hoek TL; Shao ZH
Am J Chin Med; 2010; 38(3):569-84. PubMed ID: 20503473
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity.
Yamada Y; Munechika R; Kawamura E; Sakurai Y; Sato Y; Harashima H
J Pharm Sci; 2017 Sep; 106(9):2428-2437. PubMed ID: 28478130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
